{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:19:47Z","timestamp":1772119187367,"version":"3.50.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Heilongjiang provincial administration of Traditional Chinese\n                    Medicine","award":["ZHY2022117"],"award-info":[{"award-number":["ZHY2022117"]}]},{"name":"Heilongjiang provincial administration of Traditional Chinese\n                    Medicine","award":["ZHY2022117"],"award-info":[{"award-number":["ZHY2022117"]}]},{"name":"Heilongjiang provincial administration of Traditional Chinese\n                    Medicine","award":["ZHY2022117"],"award-info":[{"award-number":["ZHY2022117"]}]},{"name":"Heilongjiang provincial administration of Traditional Chinese\n                    Medicine","award":["ZHY2022117"],"award-info":[{"award-number":["ZHY2022117"]}]},{"name":"Heilongjiang provincial administration of Traditional Chinese\n                    Medicine","award":["ZHY2022117"],"award-info":[{"award-number":["ZHY2022117"]}]},{"name":"Heilongjiang provincial administration of Traditional Chinese\n                    Medicine","award":["ZHY2022117"],"award-info":[{"award-number":["ZHY2022117"]}]},{"name":"Heilongjiang provincial administration of Traditional Chinese\n                    Medicine","award":["ZHY2022117"],"award-info":[{"award-number":["ZHY2022117"]}]},{"name":"Heilongjiang provincial administration of Traditional Chinese\n                    Medicine","award":["ZHY2022117"],"award-info":[{"award-number":["ZHY2022117"]}]},{"DOI":"10.13039\/501100005046","name":"National Science Foundation of Heilongjiang Province","doi-asserted-by":"crossref","award":["H2015044, LH2021H102,\n                    LH2020H096"],"award-info":[{"award-number":["H2015044, LH2021H102,\n                    LH2020H096"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005046","name":"National Science Foundation of Heilongjiang Province","doi-asserted-by":"crossref","award":["H2015044, LH2021H102,\n                    LH2020H096"],"award-info":[{"award-number":["H2015044, LH2021H102,\n                    LH2020H096"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005046","name":"National Science Foundation of Heilongjiang Province","doi-asserted-by":"crossref","award":["H2015044, LH2021H102,\n                    LH2020H096"],"award-info":[{"award-number":["H2015044, LH2021H102,\n                    LH2020H096"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005046","name":"National Science Foundation of Heilongjiang Province","doi-asserted-by":"crossref","award":["H2015044, LH2021H102,\n                    LH2020H096"],"award-info":[{"award-number":["H2015044, LH2021H102,\n                    LH2020H096"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005046","name":"National Science Foundation of Heilongjiang Province","doi-asserted-by":"crossref","award":["H2015044, LH2021H102,\n                    LH2020H096"],"award-info":[{"award-number":["H2015044, LH2021H102,\n                    LH2020H096"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005046","name":"National Science Foundation of Heilongjiang Province","doi-asserted-by":"crossref","award":["H2015044, LH2021H102,\n                    LH2020H096"],"award-info":[{"award-number":["H2015044, LH2021H102,\n                    LH2020H096"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005046","name":"National Science Foundation of Heilongjiang Province","doi-asserted-by":"crossref","award":["H2015044, LH2021H102,\n                    LH2020H096"],"award-info":[{"award-number":["H2015044, LH2021H102,\n                    LH2020H096"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005046","name":"National Science Foundation of Heilongjiang Province","doi-asserted-by":"crossref","award":["H2015044, LH2021H102,\n                    LH2020H096"],"award-info":[{"award-number":["H2015044, LH2021H102,\n                    LH2020H096"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"crossref"}]},{"name":"college student entrepreneurship project of Heilongjiang University of\n                    Traditional Chinese Medicine","award":["X202310228034,\n                    202310228042X"],"award-info":[{"award-number":["X202310228034,\n                    202310228042X"]}]},{"name":"college student entrepreneurship project of Heilongjiang University of\n                    Traditional Chinese Medicine","award":["X202310228034,\n                    202310228042X"],"award-info":[{"award-number":["X202310228034,\n                    202310228042X"]}]},{"name":"college student entrepreneurship project of Heilongjiang University of\n                    Traditional Chinese Medicine","award":["X202310228034,\n                    202310228042X"],"award-info":[{"award-number":["X202310228034,\n                    202310228042X"]}]},{"name":"college student entrepreneurship project of Heilongjiang University of\n                    Traditional Chinese Medicine","award":["X202310228034,\n                    202310228042X"],"award-info":[{"award-number":["X202310228034,\n                    202310228042X"]}]},{"name":"college student entrepreneurship project of Heilongjiang University of\n                    Traditional Chinese Medicine","award":["X202310228034,\n                    202310228042X"],"award-info":[{"award-number":["X202310228034,\n                    202310228042X"]}]},{"name":"college student entrepreneurship project of Heilongjiang University of\n                    Traditional Chinese Medicine","award":["X202310228034,\n                    202310228042X"],"award-info":[{"award-number":["X202310228034,\n                    202310228042X"]}]},{"name":"college student entrepreneurship project of Heilongjiang University of\n                    Traditional Chinese Medicine","award":["X202310228034,\n                    202310228042X"],"award-info":[{"award-number":["X202310228034,\n                    202310228042X"]}]},{"name":"college student entrepreneurship project of Heilongjiang University of\n                    Traditional Chinese Medicine","award":["X202310228034,\n                    202310228042X"],"award-info":[{"award-number":["X202310228034,\n                    202310228042X"]}]},{"name":"postgraduate funds for Heilongjiang University of Traditional Chinese\n                    Medicine","award":["2023yjscx031"],"award-info":[{"award-number":["2023yjscx031"]}]},{"name":"postgraduate funds for Heilongjiang University of Traditional Chinese\n                    Medicine","award":["2023yjscx031"],"award-info":[{"award-number":["2023yjscx031"]}]},{"name":"postgraduate funds for Heilongjiang University of Traditional Chinese\n                    Medicine","award":["2023yjscx031"],"award-info":[{"award-number":["2023yjscx031"]}]},{"name":"postgraduate funds for Heilongjiang University of Traditional Chinese\n                    Medicine","award":["2023yjscx031"],"award-info":[{"award-number":["2023yjscx031"]}]},{"name":"postgraduate funds for Heilongjiang University of Traditional Chinese\n                    Medicine","award":["2023yjscx031"],"award-info":[{"award-number":["2023yjscx031"]}]},{"name":"postgraduate funds for Heilongjiang University of Traditional Chinese\n                    Medicine","award":["2023yjscx031"],"award-info":[{"award-number":["2023yjscx031"]}]},{"name":"postgraduate funds for Heilongjiang University of Traditional Chinese\n                    Medicine","award":["2023yjscx031"],"award-info":[{"award-number":["2023yjscx031"]}]},{"name":"postgraduate funds for Heilongjiang University of Traditional Chinese\n                    Medicine","award":["2023yjscx031"],"award-info":[{"award-number":["2023yjscx031"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00210-024-03453-5","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T01:25:08Z","timestamp":1727745908000},"page":"3617-3629","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["RETRACTED ARTICLE: Effect of Danhong\n            injection on pharmacokinetics and pharmacodynamics of rivaroxaban in rats"],"prefix":"10.1007","volume":"398","author":[{"given":"Weihong","family":"Yin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoyang","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"issue":"23Suppl 1","key":"3453_CR1","doi-asserted-by":"publisher","first-page":"I9","DOI":"10.1161\/01.CIR.0000078469.07362.E6","volume":"107","author":"FA Anderson Jr","year":"2003","unstructured":"Anderson FA Jr, Spencer FA (2003) Risk factors for venous\n                    thromboembolism. Circulation 107(23Suppl 1):I9\u2013I16. https:\/\/doi.org\/10.1161\/01.CIR.0000078469.07362.E6","journal-title":"Circulation"},{"issue":"3","key":"3453_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2174\/18756212MTA1oOTYh3","volume":"19","author":"S Balta","year":"2021","unstructured":"Balta S (2021) Endothelial dysfunction and inflammatory markers of\n                    vascular disease. Curr Vasc Pharmacol 19(3):243\u2013249","journal-title":"Curr Vasc Pharmacol"},{"key":"3453_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3389\/fped.2018.00142","volume":"6","author":"BR Branchford","year":"2018","unstructured":"Branchford BR, Carpenter SL (2018) The Role of Inflammation in\n                    Venous Thromboembolism. Front Pediatr 6:142","journal-title":"Front Pediatr"},{"issue":"7","key":"3453_CR4","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1111\/bcp.13934","volume":"85","author":"A Brings","year":"2019","unstructured":"Brings A, Lehmann ML, Foerster KI, Burhenne J, Weiss J, Haefeli WE,\n                    Czock D (2019) Perpetrator effects of ciclosporin (P-glycoprotein inhibitor) and\n                    its combination with fluconazole (CYP3A inhibitor) on the pharmacokinetics of\n                    rivaroxaban in healthy volunteers. Br J Clin Pharmacol 85(7):1528\u20131537. https:\/\/doi.org\/10.1111\/bcp.13934","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"3453_CR5","first-page":"70","volume":"27","author":"HQ Chai","year":"2019","unstructured":"Chai HQ (2019) Clinical efficacy of Danhong injection combined with\n                    rivaroxaban in the treatment of acute pulmonary embolism and its effect on blood\n                    clotting function, vascular endothelial function and inflammatory reaction.\n                    Pract J Card Cereb Pneumal Vasc Dis 27(1):70\u201374","journal-title":"Pract J Card Cereb Pneumal Vasc Dis"},{"issue":"13","key":"3453_CR6","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1001\/jama.2017.13883","volume":"318","author":"SH Chang","year":"2017","unstructured":"Chang SH, Chou IJ, Yeh YH, Chiou MJ, Wen MS, Kuo CT, See LC, Kuo CF\n                    (2017) Association Between Use of Non-Vitamin K Oral Anticoagulants With and\n                    Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial\n                    Fibrillation. JAMA 318(13):1250\u20131259. https:\/\/doi.org\/10.1001\/jama.2017.13883","journal-title":"JAMA"},{"issue":"9","key":"3453_CR7","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3389\/fphys.2018.00991","volume":"26","author":"J Chen","year":"2018","unstructured":"Chen J, Wei J, Huang Y, Ma Y, Ni J, Li M, Zhu Y, Gao X, Fan G\n                    (2018) Danhong Injection Enhances the Therapeutic Efficacy of Mesenchymal Stem\n                    Cells in Myocardial Infarction by Promoting Angiogenesis. Front Physiol\n                    26(9):991. https:\/\/doi.org\/10.3389\/fphys.2018.00991","journal-title":"Front Physiol"},{"issue":"6","key":"3453_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/NRL.0000000000000399","volume":"27","author":"R Chen","year":"2022","unstructured":"Chen R, Yan L, Xie P, Tian J, Zhao Y, Liu Y, Xu J, Wang Y, Zhao L\n                    (2022) Use of Diterpene Ginkgolides Meglumine Injection to Regulate Plasma\n                    Levels of PAI-1 and t-PA in Patients With Acute Atherosclerotic Cerebral\n                    Infarction. Neurologist 27(6):299\u2013303. https:\/\/doi.org\/10.1097\/NRL.0000000000000399","journal-title":"Neurologist"},{"key":"3453_CR9","doi-asserted-by":"publisher","unstructured":"Chen Y, Gong X, Bao H (2023) Real-world clinical outcomes of oral\n                    anticoagulants among Japanese patients with atrial fibrillation and concomitant\n                    coronary artery disease.\u00a0IJC Heart & Vasculature\u00a049:101285. https:\/\/doi.org\/10.1016\/j.ijcha.2023.101285","DOI":"10.1016\/j.ijcha.2023.101285"},{"key":"3453_CR10","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.freeradbiomed.2016.09.006","volume":"99","author":"MY Chien","year":"2016","unstructured":"Chien MY, Chuang CH, Chern CM, Liou KT, Liu DZ, Hou YC, Shen YC\n                    (2016) Salvianolic acid A alleviates ischemic brain injury through the\n                    inhibition of inflammation and apoptosis and the promotion of neurogenesis in\n                    mice. Free Radic Biol Med 99:508\u2013519. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.09.006","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"3453_CR11","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1113\/EP089404","volume":"107","author":"P Chowdary","year":"2022","unstructured":"Chowdary P (2022) COVID-19 coagulopathy - what should we treat? Exp\n                    Physiol 107(7):749\u2013758. https:\/\/doi.org\/10.1113\/EP089404","journal-title":"Exp Physiol"},{"issue":"3","key":"3453_CR12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/bjh.13810","volume":"172","author":"BJ Dale","year":"2016","unstructured":"Dale BJ, Chan NC, Eikelboom JW (2016) Laboratory measurement of the\n                    direct oral anticoagulants. Br J Haematol 172(3):315\u2013336","journal-title":"Br J Haematol"},{"issue":"19","key":"3453_CR13","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1182\/blood-2015-08-662650","volume":"127","author":"F Denorme","year":"2016","unstructured":"Denorme F, Langhauser F, Desender L, Vandenbulcke A, Rottensteiner\n                    H, Plaimauer B, Fran\u00e7ois O et al (2016) ADAMTS13-mediated thrombolysis of\n                    t-PA-resistant occlusions in ischemic stroke in mice. Blood 127(19):2337\u20132345. https:\/\/doi.org\/10.1182\/blood-2015-08-662650","journal-title":"Blood"},{"issue":"8","key":"3453_CR14","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.4103\/njcp.njcp_125_22","volume":"25","author":"Y Dogan","year":"2022","unstructured":"Dogan Y, Az A, Sogut O, Akdemir T, Kaplan O (2022) Bleeding events\n                    in the emergency department with warfarin versus novel oral anticoagulants: A\n                    five-year analysis. Niger J Clin Pract 25(8):1308\u20131317. https:\/\/doi.org\/10.4103\/njcp.njcp_125_22","journal-title":"Niger J Clin Pract"},{"issue":"14","key":"3453_CR15","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","volume":"366","author":"HR B\u00fcller","year":"2012","unstructured":"EINSTEIN\u2013PE Investigators, B\u00fcller HR, Prins MH, Lensin AW, Decousus\n                    H, Jacobson BF et al (2012) Oral rivaroxaban for the treatment of symptomatic\n                    pulmonary embolism. N Engl J Med 366(14):1287\u201397. https:\/\/doi.org\/10.1056\/NEJMoa1113572","journal-title":"N Engl J Med"},{"issue":"7","key":"3453_CR16","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1046\/j.1538-7836.2003.00261.x","volume":"1","author":"CT Esmon","year":"2003","unstructured":"Esmon CT (2003) Inflammation and thrombosis. J Thromb Haemost\n                    1(7):1343\u20131348","journal-title":"J Thromb Haemost"},{"key":"3453_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.phrs.2018.11.006","volume":"139","author":"X Feng","year":"2019","unstructured":"Feng X, Li Y, Wang Y, Li L, Little PJ, Xu SW, Liu S (2019) Danhong\n                    injection in cardiovascular and cerebrovascular diseases: Pharmacological\n                    actions, molecular mechanisms, and therapeutic potential. Pharmacol Res\n                    139:62\u201375. https:\/\/doi.org\/10.1016\/j.phrs.2018.11.006","journal-title":"Pharmacol Res"},{"issue":"4","key":"3453_CR18","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3390\/jpm11040250","volume":"11","author":"S Fernandez","year":"2021","unstructured":"Fernandez S, Lenoir C, Samer CF, Rollason V (2021) Drug-Drug\n                    Interactions Leading to Adverse Drug Reactions with Rivaroxaban: A Systematic\n                    Review of the Literature and Analysis of VigiBase. J Pers Med 11(4):250. https:\/\/doi.org\/10.3390\/jpm11040250","journal-title":"J Pers Med"},{"issue":"6","key":"3453_CR19","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3390\/pharmaceutics14061120","volume":"14","author":"N Ferri","year":"2022","unstructured":"Ferri N, Colombo E, Tenconi M, Baldessin L, Corsini A (2022)\n                    Drug-drug interactions of direct oral anticoagulants (DOACs): from\n                    pharmacological to clinical practice. Pharmaceutics 14(6):1120","journal-title":"Pharmaceutics"},{"issue":"3","key":"3453_CR20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s11239-023-02926-3","volume":"57","author":"D Fredman","year":"2024","unstructured":"Fredman D, McNeil R, Eldar O, Leader A, Gafter-Gvili A, Avni T\n                    (2024) Efficacy and safety of rivaroxaban versus apixaban for venous\n                    thromboembolism: a systematic review and meta-analysis of observational studies.\n                    J Thromb Thrombolysis 57(3):453\u2013465. https:\/\/doi.org\/10.1007\/s11239-023-02926-3","journal-title":"J Thromb Thrombolysis"},{"key":"3453_CR21","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.jep.2013.07.039","volume":"149","author":"LN Gao","year":"2013","unstructured":"Gao LN, Cui YL, Wang QS, Wang SX (2013) Amelioration of Danhong\n                    Injection on the lipopolysaccharide-stimulated systemic acute inflammatory\n                    reaction via multi-target strategy. J Ethnopharmacol 149:772\u2013782. https:\/\/doi.org\/10.1016\/j.jep.2013.07.039","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"3453_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s40263-023-00990-0","volume":"37","author":"R Goldstein","year":"2023","unstructured":"Goldstein R, Jacobs AR, Zighan L, Gronich N, Bialer M, Muszkat M\n                    (2023) Interactions Between Direct Oral Anticoagulants (DOACs) and Antiseizure\n                    Medications: Potential Implications on DOAC Treatment. CNS Drugs 37(3):203\u2013214. https:\/\/doi.org\/10.1007\/s40263-023-00990-0","journal-title":"CNS Drugs"},{"issue":"3","key":"3453_CR23","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/bcpt.12005","volume":"112","author":"IY Gong","year":"2013","unstructured":"Gong IY, Mansell SE, Kim RB (2013) Absence of both MDR 1 (ABCB 1)\n                    and Breast Cancer Resistance Protein (ABCG 2) Transporters Significantly Alters\n                    Rivaroxaban Disposition and Central Nervous System Entry. Basic Clin Pharmacol\n                    Toxicol 112(3):164\u2013170","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"16","key":"3453_CR24","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.2146\/ajhp070624","volume":"65","author":"MP Gulseth","year":"2008","unstructured":"Gulseth MP, Michaud J, Nutescu EA (2008) Rivaroxaban: an Oral\n                    Direct Inhibitor of Factor Xa. Am J Health-Syst Pharm 65(16):1520\u20131529. https:\/\/doi.org\/10.2146\/ajhp070624","journal-title":"Am J Health-Syst Pharm"},{"issue":"1","key":"3453_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2174\/1871529X22666220418102545","volume":"22","author":"Z Heidari","year":"2022","unstructured":"Heidari Z, Daei M, Khalili H, Sahebkar A (2022) Bleeding\n                    complication in a patient with concomitant use of Rivaroxaban and Saffron\n                    supplement: a case report. Cardiovasc Hematol Disord Drug Targets 22(1):10\u20132. https:\/\/doi.org\/10.2174\/1871529X22666220418102545","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"3453_CR26","doi-asserted-by":"publisher","unstructured":"Heresi G, Abe K,\u00a0Forfia P, Kope\u0107 G, Beaudet A, Gressin V, Jevnikar\n                    M, Meijer C, Tan YZ, Moiseeva O, Sheares K, Skoro-Sajer N, Terra-Filho M,\n                    Whitford H, Zhai Z (2024) Recognition, diagnosis, and operability assessment of\n                    Chronic Thromboembolic Pulmonary Hypertension (CTEPH): a\u00a0global cross-sectional\n                    scientific survey (CLARITY).\u00a0Pulm Circ 14(1):e12330. https:\/\/doi.org\/10.1002\/pul2.12330","DOI":"10.1002\/pul2.12330"},{"issue":"8","key":"3453_CR27","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.3390\/ijms22084200","volume":"22","author":"S Huang","year":"2021","unstructured":"Huang S, Ninivaggi M, Chayoua W, de Laat B (2021) VWF, Platelets\n                    and the Antiphospholipid Syndrome. Int J Mol Sci 22(8):4200. https:\/\/doi.org\/10.3390\/ijms22084200","journal-title":"Int J Mol Sci"},{"key":"3453_CR28","doi-asserted-by":"publisher","unstructured":"Huang Y, Ge H, Wang X, Zhang X (2022) Association between blood\n                    lipid levels and lower extremity deep venous thrombosis: a population-based\n                    cohort study.\u00a0Clin Appl Thromb Hemost\u00a028:10760296221121282. https:\/\/doi.org\/10.1177\/10760296221121282","DOI":"10.1177\/10760296221121282"},{"issue":"6","key":"3453_CR29","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1111\/j.1538-7836.2010.03859.x","volume":"8","author":"ZS Huang","year":"2010","unstructured":"Huang ZS, Zeng CL, Zhu LJ, Jiang L, Li N, Hu H (2010) Salvianolic\n                    acid A inhibits platelet activation and arterial thrombosis via inhibition of\n                    phosphoinositide 3-kinase. J Thromb Haemost 8(6):1383\u20131393. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03859.x","journal-title":"J Thromb Haemost"},{"issue":"6","key":"3453_CR30","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.healun.2022.02.002","volume":"41","author":"M Humbert","year":"2022","unstructured":"Humbert M, Simonneau G, Pittrow D, Delcroix M, Pepke-Zaba J,\n                    Langleben D, Mielniczuk LM, Escribano Subias P, Snijder RJ, Barber\u00e0 JA, Klotsche\n                    J, Meier C, Hoeper MM (2022) Oral anticoagulants (NOAC and VKA) in chronic\n                    thromboembolic pulmonary hypertension. J Heart Lung Transplant 41(6):716\u2013721. https:\/\/doi.org\/10.1016\/j.healun.2022.02.002","journal-title":"J Heart Lung Transplant"},{"issue":"11","key":"3453_CR31","first-page":"977","volume":"60","author":"D Karetov\u00e1","year":"2014","unstructured":"Karetov\u00e1 D, Bultas J (2014) Extended options of anticoagulant\n                    treatment in thromboembolism. Vnitrni lekarstvi 60(11):977\u201384","journal-title":"Vnitrni lekarstvi"},{"issue":"1","key":"3453_CR32","first-page":"391","volume":"41","author":"L Kepeng","year":"2023","unstructured":"Kepeng L, QianQian L, KeWei Z et al (2023) Efficacy and Safety of\n                    Different Doses of Rivaroxaban and Risk Factors for Bleeding in Elderly Patients\n                    with Venous Thromboembolism: A Real-World, Multicenter, Observational Cohort\n                    Study. Adv Ther 41(1):391\u2013412","journal-title":"Adv Ther"},{"key":"3453_CR33","doi-asserted-by":"publisher","unstructured":"Kershaw G (2017) Performance of Activated Partial Thromboplastin\n                    Time (APTT): determining reagent sensitivity to factor deficiencies, heparin,\n                    and lupus anticoagulants.\u00a0Methods Mol Biol\u00a0(Clifton, N.J.)\u00a01646:75\u201383. https:\/\/doi.org\/10.1007\/978-1-4939-7196-1_5","DOI":"10.1007\/978-1-4939-7196-1_5"},{"issue":"10","key":"3453_CR34","doi-asserted-by":"publisher","first-page":"5825","DOI":"10.3390\/ijms23105825","volume":"23","author":"MJE Kuijpers","year":"2022","unstructured":"Kuijpers MJE, Heemskerk JWM, Jurk K (2022) Molecular Mechanisms of\n                    Hemostasis, Thrombosis and Thrombo-Inflammation. Int J Mol Sci 23(10):5825. https:\/\/doi.org\/10.3390\/ijms23105825","journal-title":"Int J Mol Sci"},{"issue":"7","key":"3453_CR35","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s40266-016-0376-z","volume":"33","author":"A Kundu","year":"2016","unstructured":"Kundu A, Sardar P, Chatterjee S, Aronow WS, Owan T, Ryan JJ (2016)\n                    Minimizing the Risk of Bleeding with NOACs in the Elderly. Drugs Aging\n                    33(7):491\u2013500. https:\/\/doi.org\/10.1007\/s40266-016-0376-z","journal-title":"Drugs Aging"},{"key":"3453_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11239-016-1420-x","volume":"43","author":"PR Kunk","year":"2017","unstructured":"Kunk PR et al (2017) Direct oral anticoagulants in hypercoagulable\n                    states. J Thromb Thrombolysis 43:79\u201385","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"3453_CR37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1055\/s-0043-118845","volume":"86","author":"C K\u00fcpper","year":"2018","unstructured":"K\u00fcpper C, Kellert L, Tiedt S, Wollenweber FA (2018) Neue orale\n                    Antikoagulantien (NOAK) in der Schlaganfall-Therapie [New oral anticoagulants\n                    (NOAC) in stroke treatment]. Fortschr Neurol Psychiatr. 86(2):117\u2013124. https:\/\/doi.org\/10.1055\/s-0043-118845. (German)","journal-title":"Fortschr Neurol Psychiatr."},{"key":"3453_CR38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.thromres.2020.07.054","volume":"195","author":"JY Lee","year":"2020","unstructured":"Lee JY, Oh IY, Lee JH, Kim SY, Kwon SS, Yang HJ, Kim YK, Bang SM\n                    (2020) The increased risk of bleeding due to drug-drug interactions in patients\n                    administered direct oral anticoagulants. Thromb Res 195:243\u2013249. https:\/\/doi.org\/10.1016\/j.thromres.2020.07.054","journal-title":"Thromb Res"},{"issue":"7","key":"3453_CR39","doi-asserted-by":"publisher","first-page":"46266","DOI":"10.1038\/srep46266","volume":"10","author":"P Li","year":"2017","unstructured":"Li P, Su W, Yun S, Liao Y, Liao Y, Liu H, Li P, Wang Y, Peng W, Yao\n                    H (2017) Toward a scientific understanding of the effectiveness, material basis\n                    and prescription compatibility of a Chinese herbal formula Dan-hong injection.\n                    Sci Rep 10(7):46266. https:\/\/doi.org\/10.1038\/srep46266","journal-title":"Sci Rep"},{"issue":"9","key":"3453_CR40","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2174\/1389200220666190827160212","volume":"20","author":"J Li","year":"2019","unstructured":"Li J, Liang Q, Sun G (2019) Interaction between Traditional Chinese\n                    Medicine and Anticoagulant \/Antiplatelet Drugs. Curr Drug Metab 20(9):701\u2013713. https:\/\/doi.org\/10.2174\/1389200220666190827160212","journal-title":"Curr Drug Metab"},{"key":"3453_CR41","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.phymed.2018.12.018","volume":"57","author":"J Li","year":"2019","unstructured":"Li J, Wang Y, Xu X, Cao W, Shen Z, Wang N, Leng J, Zou N, Shang E,\n                    Zhu Z, Guo J, Duan J (2019) Improved dialysis removal of protein-bound uremic\n                    toxins by salvianolic acids. Phytomedicine 57:166\u2013173. https:\/\/doi.org\/10.1016\/j.phymed.2018.12.018","journal-title":"Phytomedicine"},{"issue":"11","key":"3453_CR42","doi-asserted-by":"publisher","first-page":"577012","DOI":"10.3389\/fphar.2020.577012","volume":"2","author":"J Li","year":"2020","unstructured":"Li J, Lu J, Peng Y, Xu X, Chen C, Gao M, Lin L, Guo J, Duan J\n                    (2020) Characteristic and Mechanism of Drug-Herb Interaction Between\n                    Acetylsalicylic Acid and Danhong Injection Mediated by Organic Anion\n                    Transporters. Front Pharmacol 2(11):577012. https:\/\/doi.org\/10.3389\/fphar.2020.577012","journal-title":"Front Pharmacol"},{"key":"3453_CR43","doi-asserted-by":"publisher","unstructured":"Li Y, Ren TT, Liu SS et al (2024) Fingerprint analysis of\n                    dang-gui-Si-Ni decoction and its anticoagulant activity in vivo-in vitro.\u00a0J\n                    Ethnopharmacol\u00a0325:117890. https:\/\/doi.org\/10.1016\/j.jep.2024.117890","DOI":"10.1016\/j.jep.2024.117890"},{"key":"3453_CR44","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jpba.2012.12.013","volume":"76","author":"X Liu","year":"2013","unstructured":"Liu X, Wu Z, Yang K, Ding H, Wu Y (2013) Quantitative analysis\n                    combined with chromatographic fingerprint for comprehensive evaluation of\n                    Danhong injection using HPLC-DAD. J Pharm Biomed Anal 76:70\u201374. https:\/\/doi.org\/10.1016\/j.jpba.2012.12.013","journal-title":"J Pharm Biomed Anal"},{"issue":"4","key":"3453_CR45","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.thromres.2014.07.019","volume":"134","author":"L Liu","year":"2014","unstructured":"Liu L, Li J, Zhang Y, Zhang S, Ye J, Wen Z, Ding J, Kunapuli SP,\n                    Luo X, Ding Z (2014) Salvianolic acid B inhibits platelets as a P2Y12 antagonist\n                    and PDE inhibitor: evidence from clinic to laboratory. Thromb Res\n                    134(4):866\u2013876. https:\/\/doi.org\/10.1016\/j.thromres.2014.07.019","journal-title":"Thromb Res"},{"issue":"6","key":"3453_CR46","first-page":"1","volume":"27","author":"Q Liu","year":"2021","unstructured":"Liu Q, Liu H, Xing W et al (2021) Effect of Danhong Injection on\n                    Improving Coronary Microcirculation Injury after Percutaneous Coronary\n                    Intervention. Chinese Integr Med 27(6):1\u20136","journal-title":"Chinese Integr Med"},{"issue":"3","key":"3453_CR47","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1177\/08971900221074938","volume":"36","author":"V Lomakina","year":"2023","unstructured":"Lomakina V, Sozio SJ, Tekle J (2023) Use of apixaban in atrial\n                    fibrillation with ritonavir-boosted antiretroviral therapy: a case report. J\n                    Pharm Pract 36(3):728\u2013732. https:\/\/doi.org\/10.1177\/08971900221074938","journal-title":"J Pharm Pract"},{"issue":"6","key":"3453_CR48","doi-asserted-by":"publisher","first-page":"e5954","DOI":"10.1590\/1414-431X20175954","volume":"50","author":"ZG Ma","year":"2017","unstructured":"Ma ZG, Xia HQ, Cui SL, Yu J (2017) Attenuation of renal ischemic\n                    reperfusion injury by salvianolic acid B via suppressing oxidative stress and\n                    inflammation through PI3K\/Akt signaling pathway. Braz J Med Biol Res\n                    50(6):e5954. https:\/\/doi.org\/10.1590\/1414-431X20175954","journal-title":"Braz J Med Biol Res"},{"issue":"6","key":"3453_CR49","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.3892\/ijmm.2017.3166","volume":"40","author":"J Ma","year":"2017","unstructured":"Ma J, Li X, Wang Y, Yang Z, Luo J (2017) Rivaroxaban attenuates\n                    thrombosis by targeting the NF-\u03baB signaling pathway in a rat model of deep\n                    venous thrombus. Int J Mol Med 40(6):1869\u20131880. https:\/\/doi.org\/10.3892\/ijmm.2017.3166. (Retraction in: Int J Mol Med. 2018 Jun;41(6):3736.\n                    10.3892\/ijmm.2018.3565)","journal-title":"Int J Mol Med"},{"issue":"2","key":"3453_CR50","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3109\/07853890.2010.539250","volume":"43","author":"PM Mannucci","year":"2011","unstructured":"Mannucci PM, Franchini M (2011) Old and new anticoagulant drugs: a\n                    minireview. Ann Med 43(2):116\u2013123. https:\/\/doi.org\/10.3109\/07853890.2010.539250","journal-title":"Ann Med"},{"issue":"6","key":"3453_CR51","doi-asserted-by":"publisher","first-page":"e007956","DOI":"10.1161\/CIRCEP.121.007956","volume":"15","author":"PL Mar","year":"2022","unstructured":"Mar PL, Gopinathannair R, Gengler BE, Chung MK, Perez A, Dukes J,\n                    Ezekowitz MD, Lakkireddy D, Lip GYH, Miletello M, Noseworthy PA, Reiffel J,\n                    Tisdale JE, Olshansky B, from the American Heart Association Electrocardiography\n                    & Arrhythmias Committee of the Council of Clinical Cardiology (2022) Drug\n                    Interactions Affecting Oral Anticoagulant Use. Circ Arrhythm Electrophysiol\n                    15(6):e007956. https:\/\/doi.org\/10.1161\/CIRCEP.121.007956","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"3453_CR52","doi-asserted-by":"publisher","unstructured":"McCarley SC, Murphy DA, Thompson J, Shovlin CL (2023)\n                    Pharmacogenomic considerations for anticoagulant prescription in patients with\n                    hereditary haemorrhagic telangiectasia.\u00a0J Clin Med 12(24):7710. https:\/\/doi.org\/10.3390\/jcm12247710","DOI":"10.3390\/jcm12247710"},{"key":"3453_CR53","doi-asserted-by":"publisher","unstructured":"Ngo LT, Yun HY, Chae JW\u00a0(2023) Application of the population\n                    pharmacokinetics model-based approach to the prediction of drug-drug interaction\n                    between rivaroxaban and carbamazepine in humans. Pharmaceuticals (Basel,\n                    Switzerland) 16(5):684.\u00a0https:\/\/doi.org\/10.3390\/ph16050684","DOI":"10.3390\/ph16050684"},{"issue":"2","key":"3453_CR54","doi-asserted-by":"publisher","first-page":"154","DOI":"10.2174\/1871529x14666140701100338","volume":"14","author":"M Niespialowska-Steuden","year":"2014","unstructured":"Niespialowska-Steuden M, Collins P, Costopoulos C, Gorog DA (2014)\n                    NOAC in acute coronary syndrome and AF? Cardiovasc Hematol Disord Drug Targets\n                    14(2):154\u2013164. https:\/\/doi.org\/10.2174\/1871529x14666140701100338.\n                    (Erratum.In:CardiovascHematolDisordDrugTargets.2015;15(1):85)","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"3453_CR55","doi-asserted-by":"publisher","unstructured":"Otsuka Y, Poondru S, Bonate PL, Rose RH, Jamei M, Ushigome F,\n                    Minematsu T\u00a0(2023) Physiologically-based pharmacokinetic modeling to predict\n                    drug-drug interaction of enzalutamide with combined P-gp and CYP3A substrates.\u00a0J\n                    Pharmacokinet Pharmacodyn\u00a050(5):365\u2013376.\u00a0https:\/\/doi.org\/10.1007\/s10928-023-09867-7","DOI":"10.1007\/s10928-023-09867-7"},{"issue":"5","key":"3453_CR56","doi-asserted-by":"publisher","first-page":"515","DOI":"10.4103\/0019-5049.144643","volume":"58","author":"S Palta","year":"2014","unstructured":"Palta S, Saroa R, Palta A (2014) Overview of the coagulation\n                    system. Indian J Anaesth 58(5):515","journal-title":"Indian J Anaesth"},{"issue":"121","key":"3453_CR57","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ejmech.2016.05.039","volume":"4","author":"NR Patel","year":"2016","unstructured":"Patel NR, Patel DV, Murumkar PR, Yadav MR (2016) Contemporary\n                    developments in the discovery of selective factor Xa inhibitors: A review. Eur J\n                    Med Chem 4(121):671\u2013698. https:\/\/doi.org\/10.1016\/j.ejmech.2016.05.039","journal-title":"Eur J Med Chem"},{"issue":"13","key":"3453_CR58","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1515\/biol-2018-0011","volume":"10","author":"C Peng","year":"2018","unstructured":"Peng C, Duan S, Gang L (2018) Efficacy of Danhong Injection on\n                    Serum Concentration of TNF-\u03b1, IL-6 and NF-\u03baB in Rats with Intracerebral\n                    Hemorrhage. Open Life Sci 10(13):77\u201381. https:\/\/doi.org\/10.1515\/biol-2018-0011","journal-title":"Open Life Sci"},{"issue":"1","key":"3453_CR59","doi-asserted-by":"publisher","first-page":"e16639","DOI":"10.1371\/journal.pone.0016639","volume":"6","author":"NM Penrod","year":"2011","unstructured":"Penrod NM, Poku KA, Vaughan DE, Asselbergs FW, Brown NJ, Moore JH,\n                    Williams SM (2011) Epistatic interactions in genetic regulation of t-PA and\n                    PAI-1 levels in a Ghanaian population. PLoS ONE 6(1):e16639. https:\/\/doi.org\/10.1371\/journal.pone.0016639.\n                    (Erratum.In:PLoSOne.2011;6(2).doi:10.1371\/annotation\/2501cac9-f313-406f-919b-314f12b43516.Vaughn,DouglasE[correctedtoVaughan,DouglasE])","journal-title":"PLoS ONE"},{"issue":"9","key":"3453_CR60","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3390\/molecules22091443","volume":"22","author":"Y Qi","year":"2017","unstructured":"Qi Y, Zhao X, Liu H, Wang Y, Zhao C, Zhao T, Zhao B, Wang Y (2017)\n                    Identification of a Quality Marker (Q-Marker) of Danhong Injection by the\n                    Zebrafish Thrombosis Model. Molecules 22(9):1443. https:\/\/doi.org\/10.3390\/molecules22091443","journal-title":"Molecules"},{"issue":"23","key":"3453_CR61","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1001\/jama.2021.21222","volume":"326","author":"WA Ray","year":"2021","unstructured":"Ray WA, Chung CP, Stein CM, Smalley W, Zimmerman E, Dupont WD, Hung\n                    AM, Daugherty JR, Dickson A, Murray KT (2021) Association of Rivaroxaban vs\n                    Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial\n                    Fibrillation. JAMA 326(23):2395\u20132404. https:\/\/doi.org\/10.1001\/jama.2021.21222. (Erratum.In:JAMA.2022Apr5;327(13):1294.\n                    10.1001\/jama.2022.4059)","journal-title":"JAMA"},{"issue":"02","key":"3453_CR62","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/CM9.0000000000001305","volume":"134","author":"Y Ren","year":"2021","unstructured":"Ren Y, Cao SL, Li Z, Luo T, Feng B, Weng XS (2021) Comparable\n                    efficacy of 100 mg aspirin twice daily and rivaroxaban for venous\n                    thromboembolism prophylaxis following primary total hip arthroplasty: a\n                    randomized controlled trial. China Med J 134(02):164\u2013172","journal-title":"China Med J"},{"issue":"1","key":"3453_CR63","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.chest.2016.08.1462","volume":"151","author":"BT Samuelson","year":"2017","unstructured":"Samuelson BT, Cuker A, Siegal DM, Crowther M, Garcia DA (2017)\n                    Laboratory Assessment of the Anticoagulant Activity of Direct Oral\n                    Anticoagulants: A Systematic Review. Chest 151(1):127\u2013138. https:\/\/doi.org\/10.1016\/j.chest.2016.08.1462","journal-title":"Chest"},{"issue":"3","key":"3453_CR64","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1111\/bcp.14553","volume":"87","author":"I Scholz","year":"2021","unstructured":"Scholz I, Liakoni E, Hammann F, Grafinger KE, Duthaler U, Nagler M,\n                    Kr\u00e4henb\u00fchl S, Haschke M (2021) Effects of Hypericum perforatum (St John\u2019s wort)\n                    on the pharmacokinetics and pharmacodynamics of rivaroxaban in humans. Br J Clin\n                    Pharmacol 87(3):1466\u20131474. https:\/\/doi.org\/10.1111\/bcp.14553","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"3453_CR65","doi-asserted-by":"publisher","first-page":"649","DOI":"10.4022\/jafib.649","volume":"5","author":"N Shariff","year":"2012","unstructured":"Shariff N, Aleem A, Singh M, Li YZ, Smith SJ (2012) AF and Venous\n                    Thromboembolism - Pathophysiology, Risk Assessment and CHADS-VASc score. J Atr\n                    Fibrillation 5(3):649. https:\/\/doi.org\/10.4022\/jafib.649","journal-title":"J Atr Fibrillation"},{"issue":"2","key":"3453_CR66","first-page":"399","volume":"1","author":"GX Shen","year":"1998","unstructured":"Shen GX (1998) Vascular cell-derived fibrinolytic regulators and\n                    atherothrombotic vascular disorders (Review). Int J Mol Med\n                    1(2):399\u2013408","journal-title":"Int J Mol Med"},{"issue":"36","key":"3453_CR67","doi-asserted-by":"publisher","first-page":"20411","DOI":"10.1039\/c8ra00798e","volume":"8","author":"X Shi","year":"2018","unstructured":"Shi X, Sun R, Zhao Y, Fu R, Wang R, Zhao H, Wang Z, Tang F, Zhang\n                    N, Tian X, Yao J (2018) Promotion of autophagosome-lysosome fusion via\n                    salvianolic acid A-mediated SIRT1 up-regulation ameliorates alcoholic liver\n                    disease. RSC Adv 8(36):20411\u201320422. https:\/\/doi.org\/10.1039\/c8ra00798e","journal-title":"RSC Adv"},{"issue":"8S","key":"3453_CR68","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/S0735-1097(23)02134-4","volume":"81","author":"D Sibbing","year":"2023","unstructured":"Sibbing D, Blaha MJ, Kishore A et al (2023) Dual Pathway Inhibition\n                    Using Low dose Rivaroxaban plus loe dose aspirin in patients with cardiovascular\n                    disease: A Meta-Analysis. J Am Coll Cardiol 81(8S):1690\u20131690","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"3453_CR69","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1056\/NEJMoa1510991","volume":"373","author":"DM Siegal","year":"2015","unstructured":"Siegal DM, Curnutte JT, Connolly SJ, Lu G, Conley PB, Wiens BL,\n                    Mathur VS, Castillo J, Bronson MD, Leeds JM, Mar FA, Gold A, Crowther MA (2015)\n                    Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity. N Engl J Med\n                    373(25):2413\u20132424. https:\/\/doi.org\/10.1056\/NEJMoa1510991","journal-title":"N Engl J Med"},{"issue":"4","key":"3453_CR70","first-page":"983","volume":"93","author":"PA Suwanabol","year":"2013","unstructured":"Suwanabol PA, Hoch JR (2013) Venous thromboembolic disease. Surg\n                    Clin 93(4):983\u2013995","journal-title":"Surg Clin"},{"issue":"4","key":"3453_CR71","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/qjmed\/hcv177","volume":"109","author":"J Thachil","year":"2016","unstructured":"Thachil J (2016) Is NOAC without monitoring as good as warfarin?\n                    QJM 109(4):286. https:\/\/doi.org\/10.1093\/qjmed\/hcv177","journal-title":"QJM"},{"key":"3453_CR72","doi-asserted-by":"crossref","unstructured":"Thi L N ,SungYoon Y ,Thi Q T , et al.Effects of Carbamazepine and\n                    Phenytoin on Pharmacokinetics and Pharmacodynamics of Rivaroxaban. [J].\n                    Pharmaceutics, 2020,12 (11):1040\u20131040.","DOI":"10.3390\/pharmaceutics12111040"},{"issue":"6","key":"3453_CR73","doi-asserted-by":"publisher","first-page":"e206424","DOI":"10.1001\/jamanetworkopen.2020.6424","volume":"3","author":"CT Tsai","year":"2020","unstructured":"Tsai CT, Liao JN, Chiang CE, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan\n                    TC, Chung FP, Chao TF, Lip GYH, Chen SA (2020) Association of Ischemic Stroke,\n                    Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K\n                    Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a\n                    History of Intracranial Hemorrhage. JAMA Netw Open 3(6):e206424. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.6424","journal-title":"JAMA Netw Open"},{"issue":"3","key":"3453_CR74","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11739-016-1411-0","volume":"11","author":"P Verdecchia","year":"2016","unstructured":"Verdecchia P, Angeli F, Aita A, Bartolini C, Reboldi G (2016) Why\n                    switch from warfarin to NOACs? Intern Emerg Med 11(3):289\u2013293. https:\/\/doi.org\/10.1007\/s11739-016-1411-0","journal-title":"Intern Emerg Med"},{"key":"3453_CR75","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s40262-014-0188-4","volume":"54","author":"C Wagner","year":"2014","unstructured":"Wagner C et al (2014) Predicting the effect of cytochrome P450\n                    inhibitors on substrate drugs: analysis of physiologically based pharmacokinetic\n                    modeling submissions to the US Food and Drug Administration. Clin Pharmacokinet\n                    54:117\u2013127","journal-title":"Clin Pharmacokinet"},{"issue":"15","key":"3453_CR76","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12944-016-0202-y","volume":"18","author":"X Wang","year":"2016","unstructured":"Wang X, Chen Q, Pu H, Wei Q, Duan M, Zhang C, Jiang T, Shou X,\n                    Zhang J, Yang Y (2016) Adiponectin improves NF-\u03baB-mediated inflammation and\n                    abates atherosclerosis progression in apolipoprotein E-deficient mice. Lipids\n                    Health Dis 18(15):33. https:\/\/doi.org\/10.1186\/s12944-016-0202-y","journal-title":"Lipids Health Dis"},{"issue":"13","key":"3453_CR77","doi-asserted-by":"publisher","first-page":"950525","DOI":"10.3389\/fphar.2022.950525","volume":"19","author":"X Wang","year":"2022","unstructured":"Wang X, Fa J, Zhang Y, Huang S, Liu J, Gao J, Xing L, Liu Z, Wang X\n                    (2022) Evaluation of Herb-Drug Interaction Between Danshen and Rivaroxaban in\n                    Rat and Human Liver Microsomes. Front Pharmacol 19(13):950525. https:\/\/doi.org\/10.3389\/fphar.2022.950525.\n                    (Erratum.In:FrontPharmacol.2022Oct05;13:1039267)","journal-title":"Front Pharmacol"},{"key":"3453_CR78","doi-asserted-by":"publisher","unstructured":"Wang K, Wang A, Deng J, Yang J, Chen Q, Chen G, Ye M, Lin D (2024)\n                    Rivaroxaban down-regulates pyroptosis and the TLR4\/NF-\u03baB\/NLRP3 signaling pathway\n                    to promote flap survival.\u00a0Int Immunopharmacol\u00a0128:111568. https:\/\/doi.org\/10.1016\/j.intimp.2024.111568","DOI":"10.1016\/j.intimp.2024.111568"},{"key":"3453_CR79","first-page":"471","volume":"51","author":"GH Westrich","year":"2002","unstructured":"Westrich GH, S\u00e1nchez PM (2002) Prevention and treatment of\n                    thromboembolic disease: an overview. Instr Course Lect\n                    51:471\u2013480","journal-title":"Instr Course Lect"},{"key":"3453_CR80","doi-asserted-by":"publisher","first-page":"103206","DOI":"10.1016\/j.ijengsci.2019.103206","volume":"147","author":"WT Wu","year":"2020","unstructured":"Wu WT, Zhussupbekov M, Aubry N, Antaki JF, Massoudi M (2020)\n                    Simulation of thrombosis in a stenotic microchannel: The effects of vWF-enhanced\n                    shear activation of platelets. Int J Eng Sci 147:103206. https:\/\/doi.org\/10.1016\/j.ijengsci.2019.103206","journal-title":"Int J Eng Sci"},{"key":"3453_CR81","doi-asserted-by":"publisher","first-page":"460378","DOI":"10.1016\/j.chroma.2019.460378","volume":"1606","author":"LL Xu","year":"2019","unstructured":"Xu LL, Shang ZP, Bo T, Sun L, Guo QL, Qiao X, Ye M (2019) Rapid\n                    quantitation and identification of the chemical constituents in Danhong\n                    Injection by liquid chromatography coupled with orbitrap mass spectrometry. J\n                    Chromatogr A 1606:460378. https:\/\/doi.org\/10.1016\/j.chroma.2019.460378","journal-title":"J Chromatogr A"},{"issue":"10","key":"3453_CR82","doi-asserted-by":"publisher","first-page":"13393","DOI":"10.18632\/aging.203052","volume":"13","author":"W Xu","year":"2021","unstructured":"Xu W, Fei L, Huang CL, Li WX, Xie XD, Li Q, Chen L (2021) Dynamic\n                    changes in coagulation parameters and correlation with disease severity and\n                    mortality in patients with COVID-19. Aging (Albany NY)\n                    13(10):13393","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"3453_CR83","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/0394632015617065","volume":"29","author":"XW Yang","year":"2016","unstructured":"Yang XW, Li YH, Zhang H, Zhao YF, Ding ZB, Yu JZ, Liu CY, Liu JC,\n                    Jiang WJ, Feng QJ, Xiao BG, Ma CG (2016) Safflower Yellow regulates microglial\n                    polarization and inhibits inflammatory response in LPS-stimulated Bv2 cells. Int\n                    J Immunopathol Pharmacol 29(1):54\u201364. https:\/\/doi.org\/10.1177\/0394632015617065","journal-title":"Int J Immunopathol Pharmacol"},{"key":"3453_CR84","doi-asserted-by":"publisher","first-page":"154880","DOI":"10.1016\/j.phymed.2023.154880","volume":"116","author":"Q Yin","year":"2023","unstructured":"Yin Q, Zhang X, Liao S, Huang X, Wan CC, Wang Y (2023) Potential\n                    anticoagulant of traditional chinese medicine and novel targets for\n                    anticoagulant drugs. Phytomedicine 116:154880. https:\/\/doi.org\/10.1016\/j.phymed.2023.154880","journal-title":"Phytomedicine"},{"issue":"4","key":"3453_CR85","doi-asserted-by":"publisher","first-page":"e4454","DOI":"10.1002\/bmc.4454","volume":"33","author":"JX Zhang","year":"2019","unstructured":"Zhang JX, Qi MJ, Shi MZ, Chen JJ, Zhang XQ, Yang J, Zhang KZ, Han\n                    YL, Guo C (2019) Effects of Danhong injection, a traditional Chinese medicine,\n                    on nine cytochrome P450 isoforms in vitro. Biomed Chromatogr 33(4):e4454. https:\/\/doi.org\/10.1002\/bmc.4454","journal-title":"Biomed Chromatogr"},{"issue":"11","key":"3453_CR86","doi-asserted-by":"publisher","first-page":"e16097","DOI":"10.7717\/peerj.16097","volume":"27","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Zhang Z, Chen W, Zheng H, Si D, Zhang W (2023)\n                    Rivaroxaban, a direct inhibitor of coagulation factor Xa, attenuates adverse\n                    cardiac remodeling in rats by regulating the PAR-2 and TGF-\u03b21 signaling\n                    pathways. PeerJ 27(11):e16097. https:\/\/doi.org\/10.7717\/peerj.16097","journal-title":"PeerJ"},{"key":"3453_CR87","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3389\/fphar.2017.00361","volume":"8","author":"T Zhao","year":"2017","unstructured":"Zhao T et al (2017) Specific combination of salvianolic acids as\n                    core active ingredients of Danhong injection for treatment of arterial\n                    thrombosis and its derived dry gangrene. Front Pharmacol 8:361","journal-title":"Front Pharmacol"},{"key":"3453_CR88","doi-asserted-by":"publisher","unstructured":"Zhou H, Zhu J, Wan H, Shao C, Chen T, Yang J, He Y, Wan H (2022)\n                    The combination of danhong injection plus tissue plasminogen activator\n                    ameliorates mouse tail thrombosis-induced by \u03ba-carrageenan.\u00a0Phytomedicine\n                    104:154320. https:\/\/doi.org\/10.1016\/j.phymed.2022.154320","DOI":"10.1016\/j.phymed.2022.154320"},{"issue":"11","key":"3453_CR89","first-page":"2326","volume":"7","author":"P Zuo","year":"2015","unstructured":"Zuo P, Zuo Z, Wang X, Chen L, Zheng Y, Ma G, Zhou Q (2015) Factor\n                    Xa induces pro-inflammatory cytokine expression in RAW 264.7 macrophages via\n                    protease-activated receptor-2 activation. Am J Transl Res\n                    7(11):2326\u201334","journal-title":"Am J Transl Res"}],"updated-by":[{"DOI":"10.1007\/s00210-025-04549-2","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"record-id":"68076"},{"DOI":"10.1007\/s00210-025-04549-2","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000}}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03453-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03453-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03453-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:02:22Z","timestamp":1757116942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03453-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":89,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["3453"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03453-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4781658\/v1","asserted-by":"object"}]},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]},"assertion":[{"value":"22 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00210-025-04549-2","URL":"https:\/\/doi.org\/10.1007\/s00210-025-04549-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiments on rats were approved by the animal laboratory\n                    committee of Heilongjiang University of Chinese Medicine (2021013101), and\n                    performed in compliance with the Guide for the Care and Use of Laboratory\n                    Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}